福泰制药 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
David Altshuler | 12 | -32,309 |
Stuart A Arbuckle | 11 | -53,744 |
Ourania Tatsis | 10 | -11,187 |
Bastiano Sanna | 10 | -23,021 |
Jeffrey M Leiden | 7 | -58,330 |
Amit Sachdev | 6 | -23,737 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 240 | -240 |
最近3个月 | 0 | 66,939 | -66,939 |
最近6个月 | 0 | 146,382 | -146,382 |
最近12个月 | 0 | 263,605 | -263,605 |
最近18个月 | 0 | 380,698 | -380,698 |
最近36个月 | 0 | 430,275 | -430,275 |
福泰制药 内部交易
福泰制药 最新内部交易
Kristen Ambrose | SVP & Chief Accounting Officer | 2024-04-02 | 卖出 | 240 | 7,500 |
$419
|
-5.85%
|
David Altshuler | EVP, Global Research & CSO | 2024-02-26 | 卖出 | 4,239 | 25,813 |
$425.7
|
-7.34%
|
Kristen Ambrose | SVP & Chief Accounting Officer | 2024-02-26 | 卖出 | 883 | 7,965 |
$425.7
|
-7.34%
|
Ourania Tatsis | EVP, Chief Reg. & Quality Off. | 2024-02-26 | 卖出 | 354 | 55,804 |
$425.7
|
-7.34%
|
Atkinson Edward Morrow Iii | EVP, Chief Technical Ops. Off. | 2024-02-26 | 卖出 | 883 | 15,972 |
$425.7
|
-7.34%
|
Stuart A Arbuckle | EVP, COO | 2024-02-26 | 卖出 | 5,034 | 49,831 |
$425.7
|
-7.34%
|
Amit Sachdev | EVP Chief Patient & Ext Af Off | 2024-02-26 | 卖出 | 3,004 | 62,772 |
$425.7
|
-7.34%
|
David Altshuler | EVP, Global Research & CSO | 2024-02-21 | 卖出 | 3,002 | 34,022 |
$421.77
|
-6.47%
|
Amit Sachdev | EVP Chief Patient & Ext Af Off | 2024-02-21 | 卖出 | 3,191 | 68,245 |
$421.77
|
-6.47%
|
Ourania Tatsis | EVP, Chief Reg. & Quality Off. | 2024-02-21 | 卖出 | 360 | 59,467 |
$421.77
|
-6.47%
|